Treatment of Clostridium difficile-associated disease (CDAD)

Medical Letter on Drugs and Therapeutics

Volumn 48, Issue 1247, 2006, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COLESTYRAMINE; FLORASTOR; IMMUNOGLOBULIN; METRONIDAZOLE; NITAZOXANIDE; PROBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAXIMIN; TOLEVAMER; VANCOMYCIN; YOGHURT;

BACTERIAL INFECTION; BIFIDOBACTERIUM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DRUG ABSORPTION; DRUG MEGADOSE; HUMAN; LACTOBACILLUS; PROPHYLAXIS; RECURRENT DISEASE; SHORT SURVEY; TRAVELLER DIARRHEA; TREATMENT DURATION; TREATMENT FAILURE; ARTICLE; PSEUDOMEMBRANOUS COLITIS;

CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; METRONIDAZOLE; VANCOMYCIN;

EID: 39049179508     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (24)

1. S Aslam and DM Musher. An update on diagnosis, treatment and prevention of Clostridium difficile-associated disease. Gastroenterol Clin N Am 2006; 35:315.
2. J Pepin et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005; 41:1254.
3. LC McDonald et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353:2433.
4. VG Loo et al. A predominantly clonal multi-institutional out-break of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353:2442.
5. LC McDonald et al. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006; 12:409.
6. DM Musher et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 2005; 40:1586.
7. J Pepin et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 2005; 40:1591.
8. DN Gerding. Metronidazole for Clostridium difficile-associated disease: Is it okay for Mom? Clin Infect Dis 2005; 40:1598.
9. FA Zar et al. Vancomycin (V) is superior to metronidazole (M) in the treatment of severe Clostridium difficile-associated diarrhea (CDAD). 44th Annual Meeting of IDSA in Toronto, Canada, October 12-15, 2006; page 60, abstract 686.
10. JG Bartlett. New drugs for Clostridium difficile infection. Clin Infect Dis 2006; 43:428.
11. J Pepin et al. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada. Clin Infect Dis 2006: 42:758.
12. K Koss et al. The outcome of surgery in fulminant Clostridium difficile colitis. Colorectal Dis 2006; 8:149.
13. MH Wilcox. Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea. J Antimicrob Chemother 2004; 53:882.
14. S McPherson et al. Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea. Dis Colon Rectum 2006; 49:640.
15. TJ Louie et al for the Tolevamer Study Investigator Group. Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea. Clin Infect Dis 2006; 43:411.
16. Rifaximin (Xifaxan) for travelers' diarrhea. Med Lett Drugs Ther 2004; 46:74.
17. M Boero et al. Treatment for colitis caused by Clostridium difficile: results of a randomized, open-label study of rifaximin vs. vancomycin [Italian]. Microbiol Medica 1990; 5:74.
18. L Gerard et al. Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections. Expert Rev Anti Infect Ther 2005; 3:201.
19. Nitazoxanide (Alinia) - a new anti-protozoal agent. Med Lett Drugs Ther 2003; 45:29.
20. DM Musher et al. Nitazoxanide for the treatment of Clostridium difficile colitis. Clin Infect Dis 2006; 43:421.
21. J Aas et al. Recurrent Clostridium difficile colitis: case series involving 18 patients threated with donor stool administered via a nasogastric tube. Clin Infect Dis 2003; 36:580.
22. CM Surawicz et al. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 2000; 31:1012.
23. N Dendukuri et al. Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review. CMAJ 2005; 173:167.
24. M Wullt et al. Activity of three disinfectants and acidified nitrite against Clostridium difficile spores. Infect Control Hosp Epidemiol 2003; 24:765.